Expert Q&As
First interactions with EMA - Q&A 6
What CMC (Chemistry, Manufacturing, and Controls) expectations in the EU might surprise biopharma companies?
Access decades of experience
What’s Inside the Q&A:
CMC Expectations Unpacked
See why EU regulators demand a more “finished” manufacturing story than their US counterparts.
Data Depth & Readiness
Understand how much earlier Europe expects full stability data, validation, and control strategies.
Specification Standards
Explore how tighter impurity and quality thresholds can reshape your submission timeline.
Avoiding CMC Surprises
Learn how early alignment and proactive validation prevent costly delays at EMA review.
Download our Expert Q&A
Discover our latest news
Expert Q&As
Launching in EU - Q&A 6
How do we ensure compliance with local promotional regulations and get our marketing materials approved in Europe?
Expert Q&As
Launching in EU - Q&A 1
Why is launching a drug in Europe different from launching in the US?
Expert Q&As
Launching in EU - Q&A 2
How should we go about hiring and building a European presence?
